基因敲除
极低密度脂蛋白
细胞
肾透明细胞癌
清除单元格
低密度脂蛋白受体
生物
受体
癌症研究
内分泌学
脂蛋白
肾细胞癌
内科学
胆固醇
化学
细胞培养
医学
生物化学
遗传学
作者
Jeanna Perman Sundelin,Marcus Ståhlman,Annika Lundqvist,Max Levin,Paolo Parini,Martin Johansson,Jan Borén
出处
期刊:PLOS ONE
[Public Library of Science]
日期:2012-11-19
卷期号:7 (11): e48694-e48694
被引量:55
标识
DOI:10.1371/journal.pone.0048694
摘要
Clear-cell renal cell carcinoma (RCC) is, in most cases, caused by loss of function of the tumor suppressor gene von Hippel-Lindau, resulting in constitutive activation of hypoxia-inducible factor (HIF)-1α and expression of hypoxia-induced genes in normoxic conditions. Clear-cell RCC cells are characterized histologically by accumulation of cholesterol, mainly in its ester form. The origin of the increased cholesterol remains unclear, but it is likely explained by an HIF-1α-driven imbalance between cholesterol uptake and excretion. Here, we showed that expression of the very low-density lipoprotein receptor (VLDL-R) was significantly increased in clear-cell RCC human biopsies compared with normal kidney tissue. Partial knockdown of HIF-1α in clear-cell RCC cells significantly reduced the VLDL-R expression, and knockdown of either HIF-1α or VLDL-R reduced the increased lipid accumulation observed in these cells. We also showed increased uptake of fluorescently labeled lipoproteins in clear-cell RCC cells, which was significantly reduced by knockdown of HIF-1α or VLDL-R. Taken together, our results support the concept that the pathological increase of HIF-1α in clear-cell RCC cells upregulates VLDL-R, which mediates increased uptake and accumulation of lipids. These results explain the morphological characteristics of clear-cell RCC, and open up novel possibilities for detection and treatment of clear-cell RCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI